Melgardt De Villiers

Dr. Melgardt De Villiers

University of Wisconsin Madison, School of Pharmacy, Madison, United States
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2003 in Journal of Controlled Release
Verified
Journal Article
Closed access
HAHua Ai
Hua Ai
SJSteven A Jones
Steven A Jones
MVMelgardt De Villiers
Melgardt De Villiers
YLYuri M Lvov
Yuri M Lvov

1 April 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
RYRaghuvara Yendluri
Raghuvara Yendluri
Daniel P OttoDaniel P Otto
Daniel P Otto
MVMelgardt De Villiers
Melgardt De Villiers
VVVladimir Vinokurov
Vladimir Vinokurov
YLYuri M. Lvov
Yuri M. Lvov


11 November 2013 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
SZSi-Wei Zhang
Si-Wei Zhang
MHMichelle T. Harasimowicz
Michelle T. Harasimowicz
MVMelgardt De Villiers
Melgardt De Villiers
LYLian Yu
Lian Yu

1 January 2013 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
SSSchalk J. Strydom
Schalk J. Strydom
WRWarren E. Rose
Warren E. Rose
Daniel P OttoDaniel P Otto
Daniel P Otto
WLWilna Liebenberg
Wilna Liebenberg
MVMelgardt De Villiers
Melgardt De Villiers

1 June 2004 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
WYWenzhan Yang
Wenzhan Yang
MVMelgardt De Villiers
Melgardt De Villiers
The solubilization of the practically water insoluble drug furosemide by guest:host inclusion complexation with 4-sulphonic calix[n]arenes has been reported. The 4-sulphonic calix[n]arenes are water-soluble phenolic cyclooligomers that form inclusion complexes with neutral molecules. The solubility of furosemide in acidic (pH < 4) aqueous solutions containing increasing concentrations of the calixarenes was determined at 30°C and the concentration of furosemide in solution was determined by HPLC. Results showed that the molecular size of the 4-sulphonic calix[n]arenes and the concentration of the calix[n]arenes significantly influenced the increase in the solubility of furosemide. 4-Sulphonic calix[6]arene improved the solubility of furosemide the most (± 104%) followed by 4-sulphonic calix[8]-arene (±84–102%), while 4-sulphonic calix[4]arene increased the solubility of furosemide the least (±73–81%). The increase in furosemide solubility afforded by the calixarenes was most probably the result of the incorporation of the non-polar portions of the furosemide molecule into the non-polar cavities of the calixarenes similar to furosemide:cyclodextrin complexes. The driving force for this interaction was the reduction in the non-polar-water interfacial surface area when the furosemide (guest) molecules were inserted into the 4-sulphonic calix[n]arenes (host).